您好,欢迎来到佐思信息
全国服务热线:
400-009-0050
佐思信息专注支持企业决策
您当前的位置:首页>>研究报告>>其他医疗设备

2016-2021年器官保存市场分析报告
Organ Preservation Market by Preservation Solution(UW/Custodiol HTK/Perfadex), Transportation Technique (Static Cold Storage/Hypothermic Machine Perfusion/Normothermic Machine Perfusion) & Organ Type(Kidneys/liver/lung) - Analysis & Forecasts to 2021

2016-2021年器官保存市场分析报告
【报告编号】:No.25863
【发布时间】:2016-07
【关 键 字】:organ preservation     器官保存        
【报告页数】:128页
【报告价格】:电子版:5650美元
【交付方式】:Email发送或EMS快递
【订购热线】:


400-009-0050(全国24小时服务)
北京:010-82863481
上海:021-64871266 021-64872612

报告目录下载订购协议下载在线咨询

    专业、专注于为企业提供真正有价值的全球市场调查信息,是我们的使命。我们是中国第一家汇集全球众多行业研究机构研究成果的平台,致力于为企业决策提供最有效的市场资讯,特别是为中国企业了解和进入国际市场迈出第一步,提供全面的信息参考,我们跨越语言及时间的障碍,在信息爆炸的当下,努力为客户提供最有价值的全球产业资讯。我们公司也拥有独立的研究机构,聚焦于中国市场的研究,为国内外企业在中国市场大展宏图提供市场研究支持。

• 我们在全球的合作伙伴>>• 我们的研究中心>>

  • 英文摘要
  • 中文摘要
  • 索取简版报告
  • 其他医疗设备行业的相关报告
Report Description
 
The organ preservation market is expected to reach USD 241.2 million in 2021 from USD 165.9 million in 2015 at a CAGR of 7.8%. Over the years, the organ preservation market, has witnessed various technological advancements. These advancements have led to a growth in the number of transplants across the globe. Some of the other factors driving the growth of the market are rising multi-organ failure cases in aging population, rising solid organ transplantation procedures, and increasing government initiatives to promote organ donation. However, the high cost of transplants is a factor that is hindering the market.
 
In 2016, the University of Wisconsin segment is expected to account for the largest share of the organ preservation market, by preservation solution. This large share can be attributed to its prolific usage in the storage of kidney, liver, and pancreas, better transplantation outcomes, less histological damage, and improved physiological function of organs. The static cold storage is expected to account for the largest share of the organ preservation market, by technique. The largest share of static cold storage can be attributed to the simplicity, low cost, and less requirement of equipment and trained personnel. Kidneys to account for the largest share, by organ type. The large share can be attributed to factors such as rising cases of kidney failure, improvements in graft survival, and long-term graft function.
 
In 2016, North America is expected to account for the largest share of the global organ preservation market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Its large share can be attributed to growing cases of kidney failure, rising organ transplants, favorable reimbursements scenario within some provinces in Canada, and novel technological advancements by U.S. players. In the coming years, the organ preservation market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in these regions can be attributed to the new regulatory framework in China, and increasing organ donations in Asia-Pacific.
 
The global organ preservation market witnesses various product offerings offered by big and small firms. Client acquisitions, approvals, market expansions were the key developments undertaken by the companies to increase their market shares and to establish a strong foothold in the global market. The major players in this market include Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), Essential Pharmaceuticals LLC (U.S.), Dr. Franz Kohler Chemie GmbH (Germany), and Waters Medical Systems LLC (U.S.), among others.
 
Reasons to Buy the Report: 
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
 
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the organ preservation market. The report analyzes organ transplants by preservation solution, technique and organ type. 
• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the organ preservation market.
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various preservation solutions and  techniques across geographies
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the organ preservation market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the organ preservation market.
 
Table of Contents
1 INTRODUCTION 14
1.1 OBJECTIVES OF STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16
 
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH METHODOLOGY STEPS 17
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 18
2.2.1 SECONDARY RESEARCH 18
2.2.1.1 Key data from secondary sources 18
2.2.2 PRIMARY RESEARCH 20
2.2.2.1 Key data from primary sources 20
2.2.2.2 Key Insights from primary sources 21
2.2.2.3 Key industry insights 23
2.3 MARKET SIZE ESTIMATION METHODOLOGY 24
2.4 RESEARCH DESIGN 26
2.5 MARKET DATA VALIDATION AND TRIANGULATION 27
2.6 ASSUMPTIONS FOR THE STUDY 28
 
3 EXECUTIVE SUMMARY 29
3.1 CURRENT SCENARIO 29
3.2 FUTURE OUTLOOK 31
3.3 CONCLUSION 32
 
4 PREMIUM INSIGHTS 33
4.1 TRANSPLANTABLE ORGAN PRESERVATION AND TRANSPORT MARKET 33
4.2 GEOGRAPHIC ANALYSIS 34
4.3 TRANSPLANTABLE ORGAN PRESERVATION AND TRANSPORT MARKET, BY TECHNIQUE (2016 VS. 2021) 35
4.4 TRANSPLANTABLE ORGAN PRESERVATION AND TRANSPORT MARKET, BY SOLUTION (2016 VS. 2021) 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 38
5.2.1.1 Rising cases of multiple organ failure in aging population 38
5.2.1.2 Technological advancements 39
5.2.1.3 Increasing government and NGO initiatives to encourage organ donation 39
5.2.1.4 Rising number of solid-organ transplantation procedures 40
5.2.2 RESTRAINTS 42
5.2.2.1 High cost of organ transplantation 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 Normothermic machine perfusion: a new paradigm for organ preservation 43
5.2.4 CHALLENGES 44
5.2.4.1 Significant gap between number of organs donated and organs required annually 44
5.2.4.2 Limited medical reimbursements for organ donation and transplantation 44
 
6 TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET, 
BY PRESERVATION SOLUTION 46
6.1 INTRODUCTION 47
6.2 UNIVERSITY OF WISCONSIN SOLUTION (UW SOLUTION) 50
6.3 CUSTODIOL HTK 52
6.4 PERFADEX 54
6.5 OTHER PRESERVATION SOLUTIONS 56
 
7 TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET, 
BY TECHNIQUE 58
7.1 INTRODUCTION 59
7.2 STATIC COLD STORAGE (SCS) TECHNIQUE 61
7.3 HYPOTHERMIC MACHINE PERFUSION 63
7.4 NORMOTHERMIC MACHINE PERFUSION 65
 
8 TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET, 
BY ORGAN TYPE 67
8.1 INTRODUCTION 68
8.2 KIDNEYS 70
8.3 LIVER 71
8.4 LUNG 72
8.5 HEART 73
8.6 OTHER ORGANS (PANCREAS, INTESTINE) 74
 
9 TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET, 
BY REGION 75
9.1 INTRODUCTION 76
9.2 NORTH AMERICA 78
9.2.1 U.S. 79
9.2.1.1 Novel technological advancements by U.S. players 79
9.2.1.2 Growing cases of kidney failure in the U.S. 80
9.2.1.3 Huge gap between demand and supply of organs 80
9.2.2 CANADA 82
9.2.2.1 Rising organ transplants 82
9.2.2.2 Favorable reimbursement scenario for living donors within some provinces in Canada 83
9.3 EUROPE 85
9.3.1 E-4 (U.K., SPAIN, ITALY & GERMANY) 86
9.3.1.1 Active participation of the Spanish National Transplant Organization (ONT) 86
9.3.1.2 Changes in organ donation laws in Wales (U.K.) 86
9.3.1.3 Transplant scandal in Germany 87
9.3.2 REST OF EUROPE 88
9.3.2.1 Awareness campaigns in Europe 88
9.3.2.2 Lack of organ donations in Denmark 88
9.3.2.3 Family refusal, the primary barrier for organ donation in France 89
9.4 ASIA-PACIFIC 91
9.4.1 CHINA 92
9.4.1.1 New regulatory framework boosts voluntary organ donation 92
9.4.1.2 Wastage of organs 92
9.4.2 REST OF ASIA-PACIFIC 94
9.4.2.1 Increasing organ donation in Australia 94
9.4.2.2 Lack of awareness and religious beliefs in India & Japan 94
9.5 REST OF THE WORLD (ROW) 97
9.5.1 CAMPAIGNS IN BRAZIL TO ENCOURAGE ORGAN DONATION 98
9.5.2 FAVORABLE REGULATORY ENVIRONMENT IN SAUDI ARABIA, IRAN, AND ISRAEL 98
 
10 COMPETITIVE LANDSCAPE 101
10.1 OVERVIEW 101
10.2 COMPETITIVE SITUATION AND TRENDS 102
10.2.1 PRODUCT DEPLOYMENTS 102
10.2.2 APPROVALS AND CERTIFICATIONS 103
10.2.3 EXPANSIONS 104
10.2.4 OTHER STRATEGIES 104
 
11 COMPANY PROFILES 105
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 INTRODUCTION 105
11.2 PARAGONIX TECHNOLOGIES, INC. 106
11.3 21ST CENTURY MEDICINE INC. 107
11.4 DR. FRANZ KOHLER CHEMIE GMBH 108
11.5 ESSENTIAL PHARMACEUTICALS, LLC 109
11.6 LIFELINE SCIENTIFIC, INC. (ORGAN RECOVERY SYSTEMS, INC.) 110
11.7 PRESERVATION SOLUTIONS, INC. 112
11.8 XVIVO PERFUSION AB 113
11.9 TRANSMEDICS, INC. 115
11.10 ORGANOX LIMITED 116
11.11 BRIDGE TO LIFE LIMITED 117
11.12 WATERS MEDICAL SYSTEMS LLC [INSTITUT GEORGES LOPEZ (IGL)] 118
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
 
12 APPENDIX 119
12.1 DISCUSSION GUIDE OF GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET 119
12.2 OTHER DEVELOPMENTS, BY COMPANY (2012-2015) 123
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 124
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 126
12.4.1 AVAILABLE CUSTOMIZATIONS 126
12.5 RELATED REPORTS 127
 
List Of Tables
TABLE 1 NUMBER OF KIDNEY TRANSPLANTS PERFORMED ACROSS VARIOUS GEOGRAPHIES (2012-2014) 40
TABLE 2 NUMBER OF LIVER TRANSPLANTS PERFORMED ACROSS VARIOUS GEOGRAPHIES (2012-2014) 40
TABLE 3 NUMBER OF LUNG TRANSPLANTS PERFORMED ACROSS VARIOUS GEOGRAPHIES (2012-2014) 41
TABLE 4 TECHNOLOGICAL ADVANCEMENTS, THE PIVOTAL FACTOR PROPELLING THE GROWTH OF THE TRANSPLANTABLE ORGAN STORAGE & TRANSPORT MARKET 41
TABLE 5 AVERAGE COST OF KIDNEY TRANSPLANTS FOR VARIOUS COUNTRIES, 2016 42
TABLE 6 HIGH COST OF TRANSPLANT PROCEDURES RESTRAINING MARKET GROWTH 42
TABLE 7 NORMOTHERMIC MACHINE PERFUSION IN ORGAN PRESERVATION OFFERS AN ARRAY OF OPPORTUNITIES FOR THE TRANSPLANTABLE ORGAN STORAGE & TRANSPORT MARKET 43
TABLE 8 SIGNIFICANT GAP BETWEEN DEMAND AND SUPPLY OF ORGANS, A MAJOR CHALLENGE FOR THE MARKET 45
TABLE 9 GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014–2021 (USD MILLION) 48
TABLE 10 UW SOLUTION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 50
TABLE 11 NORTH AMERICAN UW SOLUTION MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 50
TABLE 12 EUROPEAN UW SOLUTION MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 51
TABLE 13 ASIA-PACIFIC UW SOLUTION MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 51
TABLE 14 CUSTODIOL HTK SOLUTION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 52
TABLE 15 NORTH AMERICAN CUSTODIOL HTK SOLUTION MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 52
TABLE 16 EUROPEAN CUSTODIOL HTK SOLUTION MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 53
TABLE 17 ASIA-PACIFIC CUSTODIOL HTK SOLUTION MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 53
TABLE 18 PERFADEX SOLUTION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 54
TABLE 19 NORTH AMERICAN PERFADEX SOLUTION MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 54
TABLE 20 EUROPEAN PERFADEX SOLUTION MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 55
TABLE 21 ASIA-PACIFIC PERFADEX SOLUTION MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 55
TABLE 22 OTHER PRESERVATION SOLUTIONS MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 56
TABLE 23 NORTH AMERICAN OTHER PRESERVATION SOLUTIONS MARKET SIZE, 
BY COUNTRY, 2014–2021 (USD MILLION) 56
TABLE 24 EUROPEAN OTHER PRESERVATION SOLUTIONS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 57
TABLE 25 ASIA-PACIFIC OTHER PRESERVATION SOLUTIONS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 57
TABLE 26 GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 60
TABLE 27 ADVANTAGES AND DISADVANTAGES OF THE SCS TECHNIQUE OF PRESERVATION OF TRANSPLANTABLE ORGANS 61
TABLE 28 STATIC COLD STORAGE (SCS) TECHNIQUE MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 62
TABLE 29 ADVANTAGES AND DISADVANTAGES OF THE HMP TECHNIQUE OF PRESERVATION OF TRANSPLANTABLE ORGANS 63
TABLE 30 HYPOTHERMIC MACHINE PERFUSION (HMP) MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 64
TABLE 31 ADVANTAGES AND DISADVANTAGES OF THE NMP TECHNIQUE OF PRESERVATION OF TRANSPLANTABLE ORGANS 65
TABLE 32 NORMOTHERMIC MACHINE PERFUSION MARKET SIZE, BY REGION, 
2014–2021 (USD MILLION) 66
TABLE 33 GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014–2021 (USD MILLION) 69
TABLE 34 TRANSPLANT MARKET SIZE FOR KIDNEYS, BY REGION, 
2014–2021 (USD MILLION) 70
TABLE 35 TRANSPLANT MARKET SIZE FOR LIVER, BY REGION, 2014–2021 (USD MILLION) 71
TABLE 36 TRANSPLANT MARKET SIZE FOR LUNGS, BY REGION, 2014–2021 (USD MILLION) 72
TABLE 37 TRANSPLANT MARKET SIZE FOR HEARTS, BY REGION, 2014–2021 (USD MILLION) 73
TABLE 38 TRANSPLANT MARKET SIZE FOR OTHER ORGANS, BY REGION, 
2014–2021 (USD MILLION) 74
TABLE 39 TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY REGION, 2014–2021 (USD MILLION) 77
TABLE 40 NORTH AMERICA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 79
TABLE 41 NUMBER OF KIDNEY TRANSPLANTS IN THE U.S., 2012-2015 80
TABLE 42 WAITING LIST OF CANDIDATES FOR ORGAN TRANSPLANTATION IN THE U.S. 
(AS OF JULY 2016) 80
TABLE 43 U.S.: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY PRESERVATION SOLUTION, 2014–2021 (USD MILLION) 81
TABLE 44 U.S.: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY TECHNIQUE, 2014–2021 (USD MILLION) 81
TABLE 45 U.S.: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY ORGAN TYPE, 2014–2021 (USD MILLION) 82
TABLE 46 ORGAN TRANSPLANTS PERFORMED IN CANADA (2012-2014) 82
TABLE 47 CANADA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014–2021 (USD MILLION) 83
TABLE 48 CANADA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 83
TABLE 49 CANADA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014–2021 (USD MILLION) 84
TABLE 50 EUROPE: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 86
TABLE 51 E-4: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY PRESERVATION SOLUTION, 2014–2021 (USD MILLION) 87
TABLE 52 E-4: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY TECHNIQUE, 2014–2021 (USD MILLION) 87
TABLE 53 E-4: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY ORGAN TYPE, 2014–2021 (USD MILLION) 88
TABLE 54 ROE: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY PRESERVATION SOLUTION, 2014–2021 (USD MILLION) 89
TABLE 55 ROE: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY TECHNIQUE, 2014–2021 (USD MILLION) 89
TABLE 56 ROE: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY ORGAN TYPE, 2014–2021 (USD MILLION) 90
TABLE 57 ASIA-PACIFIC: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 92
TABLE 58 CHINA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY PRESERVATION SOLUTION, 2014–2021 (USD MILLION) 93
TABLE 59 CHINA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY TECHNIQUE, 2014–2021 (USD MILLION) 93
TABLE 60 CHINA: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY ORGAN TYPE, 2014–2021 (USD MILLION) 94
TABLE 61 ROAPAC: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY PRESERVATION SOLUTION, 2014–2021 (USD MILLION) 95
TABLE 62 ROAPAC: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 95
TABLE 63 ROAPAC: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, BY ORGAN TYPE, 2014–2021 (USD MILLION) 96
TABLE 64 NUMBER OF ORGAN DONATIONS (2008 VS. 2015) 98
TABLE 65 ROW: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY PRESERVATION SOLUTION, 2014–2021 (USD MILLION) 99
TABLE 66 ROW: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY TECHNIQUE, 2014–2021 (USD MILLION) 99
TABLE 67 ROW: TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SIZE, 
BY ORGAN TYPE, 2014–2021 (USD MILLION) 100
TABLE 68 PRODUCT DEPLOYMENTS, 2013–2016 102
TABLE 69 APPROVALS AND CERTIFICATIONS, 2013–2016 103
TABLE 70 EXPANSIONS, 2013–2016 104
 
List Of Figures
FIGURE 1 GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET: RESEARCH METHODOLOGY STEPS 17
FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 21
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRY FOR SUPPLY SIDE 22
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY ORGANIZATION TYPE, DESIGNATION, AND REGION FOR DEMAND SIDE 22
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 24
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 25
FIGURE 7 RESEARCH DESIGN 26
FIGURE 8 DATA TRIANGULATION METHODOLOGY 27
FIGURE 9 NORTH AMERICA IS EXPECTED TO DOMINATE THE TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET IN 2016 30
FIGURE 10 HYPOTHERMIC MACHINE PERFUSION SEGMENT TO GROW AT THE HIGHEST CAGR FROM 2016 TO 2021 31
FIGURE 11 ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 32
FIGURE 12 GROWTH OPPORTUNITIES IN THE TRANSPLANTABLE ORGAN PRESERVATION AND TRANSPORT MARKET (2016-2021) 33
FIGURE 13 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 34
FIGURE 14 STATIC COLD STORAGE TECHNIQUE TO COMMAND LARGEST SHARE IN 2016 35
FIGURE 15 UNIVERSITY OF WISCONSIN (UW) SOLUTION TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 35
FIGURE 16 MARKET SEGMENTATION 37
FIGURE 17 TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SEGMENTATION, BY PRESERVATION SOLUTION 47
FIGURE 18 THE UNIVERSITY OF WISCONSIN SOLUTION TO ACCOUNT FOR THE LARGEST SHARE OF THE TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET 
IN 2016 49
FIGURE 19 GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SEGMENTATION, BY TECHNIQUE 59
FIGURE 20 STATIC COLD STORAGE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MEDICAL ANIMATION MARKET (2016-2021) 60
FIGURE 21 TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET SEGMENTATION, BY ORGAN TYPE 68
FIGURE 22 KIDNEYS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET (2016-2021) 69
FIGURE 23 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE GLOBAL TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET IN 2016 76
FIGURE 24 NORTH AMERICAN TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET OVERVIEW 78
FIGURE 25 EUROPEAN TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET OVERVIEW 85
FIGURE 26 ASIA-PACIFIC TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET OVERVIEW 91
FIGURE 27 ROW TRANSPLANTABLE ORGAN PRESERVATION & TRANSPORT MARKET OVERVIEW 97
FIGURE 28 PRODUCT DEPLOYMENT WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS IN THE LAST THREE YEARS 101
FIGURE 29 PRODUCT MIX OF KEY PLAYERS 105
FIGURE 30 LIFELINE SCIENTIFIC, INC.: COMPANY SNAPSHOT 110
FIGURE 31 XVIVO PERFUSION AB: COMPANY SNAPSHOT 113
 

关于我们|联系我们|常见问题|服务项目|购买流程
2005-2013 All rights reserved.京ICP备05069564号-4 京公网安备110108 02010359号
全国服务热线:400-009-0050北京:010-82863481上海:021-64871266

在线客服系统